AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Frankfurt, Germany, March 26, 2020 — Innoplexus AG has been honored with the Silver Edison Award 2020 for its proprietary OntosightⓇ Explore platform. The recognition comes in the category of Artificial Intelligence & User Experience. The finalists of the Edison Awards were announced on February 11th, 2020.
OntosightⓇ Explore is a specialized life science based AI-based platform for exploring and identifying non-obvious connections between diseases, pathways, proteins/targets, and drugs. It helps to capture insights and visualize a comprehensive network of biological knowledge to better understand disease pathways and uncover novel mechanisms of action (MoA.) This expanded knowledge can drive clinical development and help to bring life saving drugs to patients.
OntosightⓇ Explore helps a researcher understand the interconnectedness of biological systems with regard to their search term, which can be a gene, target/protein, pathway, or disease. Through aggregation of all available information, it identifies all the diseases including their associated pathways and molecular interactions which are responsible for its origin and severity. Target identification is a crucial step in drug discovery as it opens a door for new therapeutic development. Researchers can leverage OntosightⓇ Explore to identify all known and potential pathways through which a treatment breakthrough can be achieved.